BeStock  

HCA Healthcare HCA

US equityMarket cap rank #198Medical Care Facilities
$475.57 +$15.24 (+3.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $476.00 +0.09%
Open$467.00
Prev close$460.33
Day range$463.50 – $479.77
Volume1.58M
Market cap$99.34B
P/E (TTM)15.8
Dividend yield0.64%

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

HCA at a glance

HCA Healthcare (HCA) is trading at $475.57, up 3.31% on the day. Its market value of $99.34B makes it the 198th largest of the 3753 companies we follow.

The 52-week range is $353.34 to $553.56. Today's price is about 61% of the way from the low to the high. Holders are behind 2.7% over twelve months, but up 10.8% across the last three months.

On the chart it holds above both the 50-day ($459.71) and 200-day ($444.42) moving averages; RSI is 49, and the last 30 sessions moved at roughly 44% annualized volatility.

Revenue for the quarter ended Sep 2026 was $19.85B, up 3.6% from a year earlier, with $1.85B of net profit (a 8.6% margin).

The stock changes hands at 15.8 times trailing earnings, 9% above its five-year average of 14.5. The median for its industry group is 20.4.

11 analysts follow the stock and the average call is "buy". The mean target, $482.88, sits 1.5% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

HCA Healthcare: the business

HCA Healthcare owns and operates hospitals and surgery centers, mostly in Florida and Texas.

What tends to move it. Admissions, payer mix and labor costs drive earnings, and changes to health insurance coverage rules are a risk.

Where the case gets weaker. Softer patient admissions or a shift toward lower-paying government coverage would pressure the revenue per patient that drives profitability, and rising labor costs combined with any tightening of insurance coverage rules would squeeze margins from both directions at once.

Written by hand by the BeStock desk and revised when a business changes. how we work. Spot something out of date? Tell us.

Key statistics

Bid / Ask$459.00 / $485.00
Average price today$474.71
Volume1.58MAvg (90d) 1.38M
Turnover$749.82M
Turnover rate1.16%of shares outstanding
Volume ratio1.25vs. recent average pace
Day amplitude3.53%
Market cap$99.34B
Float market cap$65.03B
Shares outstanding136.74M
EPS (TTM)$28.33
P/E (TTM)15.77
P/B-12.30
Book value / share-$38.67
Earnings yield6.34%
Dividend (TTM)$3.06 / shareYield 0.64%
Net profit (TTM)$5.92B
Net assets-$8.08B
30-day volatility44.1%annualized
Avg daily range (ATR)3.73%of price, 14 days
Max drawdown (1y)-33.6%-12.5% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 4 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Income

Higher trailing yield than most of BeStock’s coverage scores higher.

B
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

11 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 59.4 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation54.5
Growth65.5
Profitability70.2
Momentum75.4
Financial health12.9
Analyst view17.5

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$482.88+1.5% vs. current price
Consensus ratingBuy11 analysts covering
Morningstar fair value$413.00Price is above fair value

Wall Street’s average 12-month target is $482.88, 1.5% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $413.00, so shares trade 15.2% above that estimate. On earnings multiple, it sits in the 74th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+3.3%
1 week
-4.7%
1 month
+1.8%
3 months
+10.8%
6 months
+20.9%
Year to date
+2.2%
1 year
-2.7%
3 years
+92.5%
5 years
+91.8%
Day range
$463.50$479.77
52-week range
$353.34$553.56

Technical signals

Full technicals →
Trend readLeaning bearish

3 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-2.1%Bearish
Price vs 50-day average+3.5%Bullish
Price vs 200-day average+7.0%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)48.9Bearish
MACD (12,26,9)7.02Bearish
Bollinger band position37%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How HCA ranks on BeStock

Market value#198 of 3734
P/E (cheapest = 1)#1288 of 2917
Dividend yield#2041 of 2245
Closeness to 52-week high#973 of 3724
Dollar volume today#201 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

Set against the peer table: at 15.8x earnings, HCA looks about mid-pack against the market, and trades 23% below the 20.4x median among Medical Care Facilities names. The two comparisons do not always agree.

HCA is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on HCA.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on HCA

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

HCA stock: common questions

Where is HCA trading right now?

$475.57 is the latest print for HCA, a move of +3.31% against yesterday's close of $460.33. Today's low and high so far: $463.50 and $479.77.

How big is HCA Healthcare?

Equity value comes to $99.34B at the current price. By that measure it is number 198 of the 3753 names in our coverage.

What multiple of earnings does HCA sell for?

Buyers pay 15.8 times the last twelve months of profit (EPS $28.33). Averaged over five years the multiple has been 14.5, and today's level ranks in the 74th percentile of its own history.

Is HCA near its 52-week high or low?

The year's floor is $353.34 and the ceiling $553.56. Shares are 14.1% away from that ceiling.

Does HCA Healthcare pay a dividend?

It does. Payouts over the past twelve months work out to a 0.64% yield; the latest ex-dividend date was September 16, 2026.

Is HCA rated a buy by Wall Street?

Of 11 analysts, 64% say buy, 27% hold and 9% sell. Price targets average $482.88, with the most cautious at $380.00 and the most optimistic at $570.00.

What kind of company is HCA Healthcare?

HCA Healthcare owns and operates hospitals and surgery centers, mostly in Florida and Texas.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on HCA.

Sign in to join the discussion.

Scroll to Top